Effect of single and repeated methamphetamine treatment on neurotransmitter release in substantia nigra and neostriatum of the rat

Journal of Neurochemistry

Volumn 83, Issue 3, 2002, Pages 645-654

  Bustamante, Diego ^a   You, Zhi Bing ^b   Castel, Marie Noëlle ^b   Johansson, Sara ^b   Goiny, Michel ^b   Terenius, Lars ^b   Hökfelt, Tomas ^b   Herrera Marschitz, Mario ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Amino acids; Basal ganglia; Dynorphin; Methamphetamine; Microdialysis; Monoamines

Indexed keywords

4 AMINOBUTYRIC ACID; ASPARTIC ACID; BRAIN MONOAMINE; DOPAMINE; DYNORPHIN B; GLUTAMIC ACID; METHAMPHETAMINE;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; CONTROLLED STUDY; DEPOLARIZATION; MALE; MICRODIALYSIS; NEOSTRIATUM; NEUROTRANSMISSION; NONHUMAN; POTASSIUM DEPLETION; POTASSIUM TRANSPORT; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SUBSTANTIA NIGRA;

AMINO ACIDS; ANIMALS; ASPARTIC ACID; BIOGENIC MONOAMINES; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DYNORPHINS; ENDORPHINS; EXTRACELLULAR SPACE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; MALE; METHAMPHETAMINE; MICRODIALYSIS; NEOSTRIATUM; NEUROTRANSMITTER AGENTS; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

ANIMALIA;

EID: 0036829069     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2002.01171.x     Document Type: Article

References (75)

1. Abekawa T., Ohmori T. and Koyama T. (1994) Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643, 276-281.
2. Adachi Y. U., Watanabe K., Satoh T. and Vizi E. S. (2001) Halothane potentiates the effect of methamphetamine and nomifensine on extracellular dopamine levels in rat striatum: A microdialysis study. Br. J. Anaesth. 86, 837-845.
3. Alburges M. E., Keefe K. A. and Hanson G. R. (2001a) Contrasting responses by basal ganglia met-enkephalin systems to low and high doses of methamphetamine in a rat model. J. Neurochem. 76, 721-729.
4. Alburges M. E., Keefe K. A. and Hanson G. R. (2001b) Unique responses of limbic met-enkephalin systems to low and high doses of methamphetamine. Brain Res. 905, 120-126.
5. Axt K. J. and Molliver M. E. (1991) Immunohistochemical evidence for methamphetamine-induced serotonergic axon loss in the rat brain. Synapse 9, 302-313.
6. Battaglia G., Fornai F., Busceti C. L., Cerrito F., De Blasi A., Melchiorri D. and Nicoletti F. (2002) Selective blockade of mGlu5 metabotropic glutamate receptors is protective against methamphetamine neurotoxicity. J. Neurosci. 22, 2135-2141.
7. Brown J. M., Hanson G. R. and Fleckenstein A. E. (2000) Methamphetamine rapidly decreases vesicular dopamine uptake. J. Neurochem. 74, 2221-2223.
8. Brunswick D. J., Benmasour S., Tejani-Butt S. M. and Hauptmann M. (1992) Effects of high-dose methamphetamine on monoamine uptake sites in rat brain measured by quantitative autoradiography. Synapse 11, 287-293.
9. Burrows K. B. and Meshul C. K. (1997) Methamphetamine alters presynaptic glutamate immunoreactivity in the caudate nucleus and motor cortex. Synapse 27, 133-144.
10. Burrows K. B. and Meshul C. K. (1999) High-dose methamphetamine treatment alters presynaptic GABA and glutamate immunoreactivity. Neuroscience 90, 833-850.
11. Butcher S. P., Fairbrother I. S., Kelly J. S. and Arbuthnott G. W. (1988) Amphetamine-induced release in the rat striatum: An in vivo microdialysis study. J. Neurochem. 50, 346-355.
12. Cadet J. L., Sheng P., Ali S., Rothman R., Carlson E. and Epstein C. J. (1994) Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxidase dismutase transgenic mice. J. Neurochem. 62, 380-383.
13. Cadet J. L., Ordonez S. V. and Ordonez J. V. (1997) Methamphetamine induces apoptosis in immortalized neural cells: Protection by the proto-oncogene, bcl-2. Synapse 25, 176-184.
14. Castel M. N., Morino P., Dagerlind A. and Hökfelt T. (1994) Up-regulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment. Eur. J Neurosci. 6, 646-656.
15. Chapman D. E., Hanson G. R., Kesner R. P. and Keefe K. A. (2001) Longterm changes in basal ganglia function after a neurotoxic regimen of methamphetamine. J. Pharmacol. Exp. Ther. 296, 520-527.
16. Christensson-Nylander I., Herrera-Marschitz M., Staines W., Hökfelt T., Terenius L., Ungerstedt U., Cuello C., Oertel W. H. and Goldstein M. (1986) Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical evidence. Exp. Brain Res. 64, 169-192.
17. Culbells J. F., Rayport S., Rajendran G. and Sulzer D. (1994) Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14, 2260-2271.
18. Dahlström A. and Fuxe K. (1964) Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of the brainstem neurons. Acta Physiol. Scand. 62, 1-55.
19. De Vito M. J. and Wagner G. C. (1989) Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacology 28, 1145-1150.
20. Dingledine R., Borges K., Bowie D. and Traynelis S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 8-61.
21. Eisch A. J., O'Dell S. J. and Marshall J. F. (1996) Striatal and cortical NMDA receptors are altered by a neurotoxic regimen of methamphetamine. Synapse 22, 217-225.
22. Fibiger H. C. and McGeer E. G. (1971) Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla. Eur J. Pharmacol. 16, 176-180.
23. Fleckenstein E. E., Metzger R. R., Gibb J. W. and Hanson G. R. (1997) A rapid and reversible change in dopamine transporters induced by methamphetamine. Eur. J. Pharmacol. 323, 9-10.
24. Frey K., Kilbourn M. and Robinson T. (1997) Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine. Eur J. Pharmacol. 334, 273-279.
25. Fukumura M. M., Cappon G. D., Pu C., Broening H. and Vorhees C. V. (1998) A single dose model of methamphetamine-induced neurotoxicity in rats: Effects on neostriatal monoamines and glial fibrillary acidic protein. Brain Res. 806, 1-7.
26. Gibb J. W. and Kogan F. J. (1979) Influence of dopamine synthesis on methamphetamine-induced changes in striatal and adrenal tyrosine hydroxylase activity. Naunyn-Schmiedeberg's Arch. Pharmacol. 310, 185-187.
27. Haughey J. M., Fleckenstein A. E., Metzger R. R. and Hanson G. R. (2000) The effects of methamphetamine on serotonin transporter activity: Role of dopamine and hyperthermia. J. Neurochem. 75, 1608-1617.
28. Herrera-Marschitz M., Meana J, J., O'Connor W. T., Goiny M., Reid M. S. and Ungerstedt U. (1992) Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: Reciprocal interactions. Amino Acids 2, 157-179.
29. Herrera-Marschitz M., You Z.-B., Goiny M., Meana J. J., Silveira R., Godukhin O., Chen Y., Espinoza S., Pettersson E., Loidl F., Lubec G., Andersson K., Nylander I., Terenius L. and Ungerstedt U. (1996) On the origin of extracellular glutamate levels monitored in the basal ganglia by in vivo microdialysis. J. Neurochem. 66, 1726-1735.
30. Holson R. R., Bowyer J. F., Clausing P. and Gough B. (1996) Methamphetamine-stimulated striatal dopamine release declines rapidly over time following microdialysis probe insertion. Brain Res. 739, 301-307.
31. Hotchkiss A. J. and Gibb J. W. (1980) Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase and tyrosine hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214, 257-262.
32. Hurd Y. L. and Ungerstedt U. (1989a) In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudate-putamen. Eur. J. Pharmacol. 166, 251-260.
33. Hurd Y. L. and Ungerstedt U. (1989b) Calcium dependency of amphetamine, nomifensine and Lu 19-005 effects on dopamine transmission. Eur. J. Pharmacol. 166, 261-270.
34. Kuczenski R. and Segal D. S. (1992) Differential effects of methamphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 1085-1094.
35. Marek G. J., Vosmer G. and Seiden L. S. (1990) Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons. Brain Res. 513, 274-279.
36. Marshall J. F. and Navarrete R. J. (1990) Contrasting tissue factors predict heterogeneous striatal dopamine neurotoxicity after MPTP or methamphetamine treatment. Brain Res. 534, 348-351.
37. Marshall J. F., O'Dell S. J. and Weihmuller F. B. (1993) Dopamineglutamate interactions in methamphetamine-induced neurotoxicity. J. Neural Transm. 91, 241-254.
38. Nash J. F. and Yamamoto B. K. (1992) Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3,4-methylenedioxymethamphetamine. Brain Res. 581, 237-243.
39. O'Dell S. J., Weihmuller F. B. and Marshall J. F. (1991) Multiple methamphetamine injections induce marked increases in extracellular striatal dopamine which correlate with subsequent neurotoxicity. Brain Res. 564, 256-260.
40. 2 antagonists. J. Neurochem. 60, 1792-1799.
41. Olney J. W. (1969) Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164, 719-721.
42. Patneau D. P. and Mayer M. L. (1990) Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J. Neurosci. 10, 2385-2399.
43. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
44. Pu C. and Vorhees C. V. (1993) Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocytes reaction in rat striatum. Dev. Brain Res. 72, 325-328.
45. Ricaurte G. A., Schuster C. R. and Seiden L. S. (1980) Long-term effects of repeated methylamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res. 193, 153-163.
46. Sabol K. E., Roach J. T., Broom S. L., Ferreira C. and Preau M. M. (2001) Long-term effects of a high-dose methamphetamine regimen on subsequent methamphetamine-induced dopamine release in vivo. Brain Res. 892, 122-129.
47. Schmidt C. J. and Gibb J. W. (1985) Role of the dopamine uptake carrier in the neurotoxic response to methamphetamine: Effect of Anfonelic acid. Eur. J. Pharmacol. 109, 73-80.
48. Schmidt C. J., Ritter J. K., Sonsalla P. K., Hanson G. R. and Gibb J. W. (1985) Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233, 539-544.
49. Schultzberg M., Segura-Aguilar J. and Lind C. (1988) Distribution of DT diaphorase in the rat brain: Biochemical and immunohistochemical studies. Neuroscience 27, 763-776.
50. Segura-Aguilar J., Metodiewa D. and Baez S. (2001) The possible role of one-electron reduction of aminochrome in the neurodegenerative process of the dopaminergic system. Neurotoxicity Res. 3, 157-165.
51. Seiden L. S., Fischman C. R. and Schuster C. R. (1976) Long-term methamphetamine-induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Dependence 1, 215-219.
52. Sharp T., Zetterström T. and Ungerstedt U. (1986) An in vivo study of dopamine release and metabolism in rat brain regions using intracerebral dialysis. J. Neurochem. 47, 113-121.
53. Smith A. J. and McGinty J. F. (1994) Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Mol. Brain Res. 21, 359-362.
54. 2 dopamine receptor substypes in mediating the methamphetamine-induced changes in monoamine systems. J. Pharmacol. Exp. Ther. 238, 932-937.
55. Sonsalla P. K., Nicklas W. J. and Heikkila R. E. (1989) Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 243, 398-243.
56. Stephans S. E. and Yamamoto B. K. (1994) Methamphetamine-induced neurotoxicity: Roles for glutamate and dopamine efflux. Synapse 17, 203-209.
57. Sulzer D. and Zecca L. (2000) Intraneuronal dopamine-quinone synthesis: A review. Neurotoxicity Res. 1, 181-195.
58. Sulzer D., Chen T.-K., Lau Y. Y., Kristensen H., Rayport S. and Ewing A. (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J. Neurosci. 15, 4102-4108.
59. Ungerstedt U. (1971) Stereotaxic mapping of the monoamine pathway in the rat brain. Acta Physiol. Scand. Suppl. 367, 1-48.
60. Ungerstedt U. (1984) Measurment of neurotransmitter release by intracranial microdialysis. In: Measurement of Neurotransmitter Release in Vivo (Marsden C. A., ed.), pp. 81-105. John Wiley & Sons, Chischester.
61. Ungerstedt U. (1991) Microdialysis: Principles and applications for studies in animals and man. J. Intern. Med. 230, 365-373.
62. Ungerstedt U., Herrera-Marschitz M., Jungnelius U., Ståhle L., Tossman U. and Zetterstrtöm T. (1982) Dopamine synaptic mechanisms reflected in studies combining behavioural recordings and brain dialysis. Adv. Biosci. 37, 219-231.
63. Vincent S. R., Hökfelt T., Christensson I. and Terenius L. (1982) Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway. Eur J. Pharmacol. 85, 251-252.
64. Wagner G. C., Lucot J. B., Schuster C. R. and Seiden L. S. (1983) Alpha-methyltyrosine attenuates and reserpine increases methamphetamine-induced neuronal changes. Brain Res. 270, 285-288.
65. Wallace T. L., Gudelsky G. A. and Vorhess C. V. (2001) Neurotoxic regimen of methamphetamme produces evidence of behavioural sensitisation in the rat. Synapse 39, 1-7.
66. Wang J. Q. and McGinty J. F. (1995) Dose-dependent alteration in zif/268 and preprodynorphin mRNA expression induced by amphetamine or methamphetamine in rat forebrain. J Pharmacol. Exp. Ther. 273, 909-917.
67. 2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse 22, 114-122.
68. Watkins J. C. and Evans R. H. (1981) Excitatory amino acid transmitters. Ann. Rev. Pharmacol. Toxicol. 21, 165-204.
69. Westerink B. H. C., Damsma G., DeVries J. B. and Horn A. S. (1987) Scope and limitations of in vivo brain dialysis: A comparison of its application to various neurotransmitter systems. Life Sci. 41, 1763-1776.
70. 2 receptor agonists. Neuroscience 63, 427-434.
71. You Z.-B., Nylander I., Herrera-Marschitz M., O'Connor W. T., Goiny M. and Terenius L. (1994b) The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis. I. Effects of K -depolarization, lesions and peptidase inhibition. Neuroscience 63, 415-425.
72. You Z.-B., Herrera-Marschitz M., Nylander I., Goiny M., Kehr J., Ungerstedt U. and Terenius L. (1996) Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats. Brain Res. 710, 241-248.
73. You Z.-B., Herrera-Marschitz M. and Terenius L. (1999) Modulation of neurotransmitter release in the basal ganglia of the rat brain by dynorphin peptides. J. Pharmacol. Exp. Ther. 290, 1307-1315.
74. Zetterström T., Herrera-Marschitz M. and Ungerstedt U. (1986) Simultaneous measurement of dopamine release and rotational behaviour in 6-hydroxydopamine denervated rats using intracerebral dialysis. Brain Res. 376, 1-7.
75. Zetterström T., Sharp T., Marsden C. A. and Ungerstedt U. (1983) In vivo measurement of dopamine and its metabolites studied by intracerebral dialysis: changes after D-amphetamine. J. Neurochem. 41, 1769-1773.